Life Sciences on the Rise: 2021 North American Report

PUBLIC & PRIVATE FUNDING (2020-2021)

COMPANY

DEAL TYPE

COMPLETED TYPE

$ RAISED (MM)

AbCellera

IPO

Dec 2020 Public

$483.0

Trulieve Cannabis

Public Investment 2nd Offering

Apr 2021

Public

$157.8

Virogin Biotech

Later Stage

Sep 2020 VC

$62.0

Xenon Pharmaceuticals

Public Investment 2nd Offering

Feb 2020 Public

$52.3

Eupraxia Pharmaceuticals

IPO

Mar 2021

Public

$32.4

ImmunoPrecise Antibodies

Public Investment 2nd Offering

Feb 2021

Public

$25.0

BriaCell Therapeutics

Public Investment 2nd Offering

Feb 2021

Public

$25.0

PocketPills

Early Stage

Mar 2021

VC

$23.6

Aspect Biosystems

Later Stage

Jun 2020 VC

$20.0

Precision Nanosystems

Later Stage

Feb 2021

VC

$19.7

RENT VS. VACANCY COMPARISON

NNN Rents

Vacancy Rate

$15.00 $17.00 $19.00 $21.00 $23.00 $25.00 $27.00 $29.00 $31.00 $33.00

12.0%

10.0%

8.0%

Vacancy Rate

6.0%

4.0%

NNN Rent $/sf

Vacancy Rate

2.0%

Average Asking Rent $/sf

0.0%

2015

2016

2017

2018

2019

2020

Data Represents the Overall Office Market Source: Cushman & Wakefield Research

Asking Rents

Vacancy Rate

REPRESENTATIVE LEASE TRANSACTIONS (2020)

COMPANY

ADDRESS

SIZE (SF) NEW/RENEWAL TYPE

QUARTER LANDLORD

Research/ Development Q4 2019 Wesgroup Properties

AbCellera Biologics Inc

2131 Manitoba St

48,000 New

Medipure Pharmaceuticals Inc

Canadian Urban Limited

8900 Glenlyon Pkwy 26,000 New

Research

Q4

Anandia Laboratories Inc 887 Great Northern Way 26,000 Expansion

Testing

Q4 2019 Dundee REIT

Vaccine Research

Canadian Urban Limited

Symvivo Inc

8900 Glenlyon Pkwy 18,000

New

Q3

Clarius Mobile Health Corp

2985 Virtual Way

11,000

New (Sublease) Research / Manufacture Q3

QuadReal

/ 49

Contributor: Kyle Grundy, kyle.grundy@ca.cushwake.com